$260 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 54 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FOMX | Exit | Foamix Pharmaceuticals Ltd | $0 | – | -63,202 | -100.0% | -0.13% | – |
ESPR | Exit | Esperion Therapeutics Inc | $0 | – | -10,000 | -100.0% | -0.28% | – |
ANAB | Exit | Anaptysbio Inc | $0 | – | -8,500 | -100.0% | -0.34% | – |
ACAD | Exit | Acadia Pharmaceuticals Inc | $0 | – | -42,773 | -100.0% | -0.38% | – |
TSRO | Exit | Tesaro Inc | $0 | – | -21,300 | -100.0% | -0.48% | – |
OPTN | Exit | Optinose Inc | $0 | – | -65,000 | -100.0% | -0.51% | – |
BGNE | Exit | BeiGene Ltdsponsored adr | $0 | – | -9,500 | -100.0% | -0.62% | – |
PEN | Exit | Penumbra Inc | $0 | – | -14,000 | -100.0% | -0.63% | – |
AXGN | Exit | Axogen Inc | $0 | – | -50,000 | -100.0% | -0.71% | – |
MTEM | Exit | Molecular Templates Inc | $0 | – | -247,587 | -100.0% | -0.77% | – |
RARE | Exit | Ultragenyx Pharmaceutical Inc | $0 | – | -41,000 | -100.0% | -0.82% | – |
AVXS | Exit | Avexis Inc | $0 | – | -17,000 | -100.0% | -0.82% | – |
SGYPQ | Exit | Synergy Pharmaceuticals DEL | $0 | – | -1,505,809 | -100.0% | -1.06% | – |
CLVS | Exit | Clovis Oncology Inc | $0 | – | -76,000 | -100.0% | -1.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
AMGEN INC COM | 25 | Q3 2023 | 7.9% |
NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-18 |
13F-HR | 2023-02-01 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-16 |
13F-HR | 2022-05-20 |
13F-HR | 2022-02-15 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.